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Quercetin (Q), a bioflavonoid ubiquitously distributed in vegetables, fruits, leaves, and
grains, can be absorbed, transported, and excreted after oral intake. However, little is
known about Q uptake and metabolism by macrophages. To clarify the puzzle, Q at its
noncytotoxic concentration (44mM) was incubated without or with mouse peritoneal
macrophages for different time periods. Medium alone, extracellular, and intracellular
fluids of macrophages were collected to detect changes in Q and its possible metabolites
using high-performance liquid chromatography. The results showed that Q was unstable
and easily oxidized in either the absence or the presence of macrophages. The remaining Q
and its metabolites, including isorhamnetin and an unknown Qmetabolite [possibly Qe (O-
semiquinone)], might be absorbed by macrophages. The percentage of maximal Q uptake
by macrophages was found to be 2.28% immediately after incubation; however, Q uptake
might persist for about 24 hours. Q uptake by macrophages was greater than the uptake of
its methylated derivative isorhamnetin. As Q or its metabolites entered macrophages,
those compounds were metabolized primarily into isorhamnetin, kaempferol, or unknown
endogenous Q metabolites. The present study, which aimed to clarify cellular uptake and
metabolism of Q by macrophages, may have great potential for future practical applica-
tions for human health and immunopharmacology.
Copyright © 2015, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC.
 
Open access under CC BY-NC-ND license.1. Introduction
Quercetin (Q), a typical antioxidative flavonoid ubiquitously
distributed in vegetables, fruits, leaves, and grains, can be
absorbed, transported, and excreted after oral intake, sug-
gesting that cellular uptake of quercetin aglycone and quinine
formation are possible [1]. An aglyconic version of Q can beScience and Biotechno
Lin).
ministration, Taiwan. Publfound in the blood after the digestion of quercetin glycosides
via the small intestine, although Q may conjugate with
different glycosides to form quercetin glycosides in plants.
After Q supplementation, levels of Q and its methylated
metabolite isorhamnetin in the plasma and brain increase
markedly, further indicating Q uptake and metabolism in vivo
[2]. Q, in its aglyconic form, can transiently reach any bloodlogy, National Chung Hsing University, 250 Kuokuang Road, Tai-
ished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
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about Q uptake and metabolism by macrophages.
Macrophages are the mature form of monocytes resident
in almost all tissues and are pivotal cells in innate immunity.
Macrophages are relatively long-lived and versatile cells that
perform several different functions throughout the innate
immune response and subsequent adaptive immune re-
sponses [3]. It is clear that monocytes and macrophages are
vital to immune response regulation and inflammation
development. Q was found to significantly reduce the pro-
duction of proinflammatory cytokines interleukin-6 and
tumor necrosis factor-a in THP1macrophages [4]. Recently, Q-
rich extracts from strawberry and mulberry fruits were found
to significantly decrease mouse splenocytes' tumor necrosis
factor-a/interleukin-10 (pro-/anti-inflammatory) cytokine
secretion ratios in the presence of lipopolysaccharide (LPS) in
concentration-dependent manners [5]. Most recently, it was
found that Q administered in a prophylacticmannermight act
as an immunostimulatory agent; however, Q exhibited a
therapeutic, but not prophylactic, effect on spontaneous or
LPS-induced inflammation in vivo [6]. Taken together, Q has
been considered a potent bioflavonoid, and widely used in
health foods and pharmacology. Undoubtedly, Q may affect
immune cells. However, only a few reports regarding research
on Q uptake and metabolism by macrophages were found.
Q was found to have great immunomodulation potential
in vitro and in vivo. We hypothesized that macrophages might
have a specific mechanism to Q uptake and metabolism. To
validate this assumption, Q was incubated with mouse peri-
toneal macrophages for different time periods. Extra- and
intracellular fluids from the cultures were collected. Changes
in the levels of Q and its possible metabolites were measured
using high-performance liquid chromatography (HPLC) to
clarify Q uptake and metabolism. The present study to clarify
cellular uptake and metabolism of Q by macrophages may
have great potential for its future practical applications for
human health and immunopharmacology.2. Materials and methods
2.1. Chemicals
Quercetin dihydrate (C15H10O7$2H2O; 338.27 g/mol; Sigma-
Aldrich Co., Steinheim, Switzerland) was purchased at the
highest available purity (>98%, HPLC) and dissolved in
dimethyl sulfoxide (Wako, Osaka, Japan) to prepare a stock
solution at a concentration of 20mM. The stock solution was
sterilized using a filter (Millipore, Carrigtwohill, Cork, Ireland)
with 0.22 mm pore size and stored at 80C for future use. Q,
rutin hydrate, ellagic acid, p-coumaric acid, morin, kaemp-
ferol (Sigma-Aldrich Co., Steinheim, Germany), and iso-
rhamnetin (MP Biomedicals, lllkirch, France) were purchased
at the highest available purity (>98%, HPLC) for HPLC
standards.
2.2. Source of mouse primary peritoneal macrophages
Female BALB/cByJNarl mice (6-week old) were obtained from
the National Laboratory Animal Center, National AppliedResearch Laboratories, National Science Council in Taipei,
Taiwan, R.O.C., and maintained in the Department of Food
Science and Biotechnology, National Chung Hsing University,
Taichung, Taiwan, R.O.C. Themicewere housed and kept on a
chow diet (laboratory standard diet, Diet MF 18; Oriental Yeast
Co., Ltd., Osaka, Japan). The animal room was kept on a 12-
hour-light and 12-hour-dark cycle. Constant temperature
(25 ± 2C) and relative humidity (50e75%) were maintained.
After the mice were acclimatized for 4 weeks, they were
sacrificed to obtain peritoneal macrophages. BALB/c strain
mice weighing 20e25 g were used throughout the experiment.
The animal-use protocol for these experiments was reviewed
and approved by the Institutional Animal Care and Use
Committee, National Chung Hsing University.
The primary peritoneal macrophages from mice were
collected according to the method described by Lin and Tang
[7] and Liu and Lin [8]. Briefly, the adult female BALB/c mice
were anesthetized with diethyl ether, bled using a retro-
orbital venous plexus puncture to collect blood, and immedi-
ately euthanized by CO2 inhalation. Peritoneal macrophages
were prepared by lavaging the peritoneal cavity with two ali-
quots of 5 mL sterile Hank's balanced salts solution [50 mL of
10Hank's balanced salts solution (Hyclone Laboratories Inc.,
Logan, UT, USA); 2.5 mL of antibioticeantimycotic solution
(100  penicillin-streptomycin-amphotericin (PSA)) contain-
ing 10,000 units of penicillin, 10 mg streptomycin, and 25 mg
amphotericin B per milliliter in 0.85% saline (Atlanta Bi-
ologicals Inc., Norcross, GA, USA); 20 mL of 3% bovine serum
albumin (Sigma-Aldrich Co., St. Louis, MO, USA) in phosphate-
buffered saline (PBS; 137mM NaCl, 2.7mM KCl, 8.1mM
Na2HPO4, 1.5mM KH2PO4, pH 7.4, 0.2 mm filtered); 2.5 mL of
7.5% NaHCO3 (Wako), and 425 mL sterile water], for a total of
10 mL, through peritoneum. The peritoneal lavage fluid was
centrifuged at 400  g for 10 minutes at 4C. The cell pellets
were collected and resuspended in a tissue culture medium
(TCM, a serum replacement; Celox Laboratories Inc., Lake
Zurich, IL, USA), suspended in a medium consisting of 10 mL
TCM, 500 mL Roswell Park Memorial Institute 1640 medium
(Atlanta Biologicals Inc.), and 2.5 mL antibioticeantimycotic
solution (100  PSA). The peritoneal adherent cells (>90% of
macrophages) from each animal were pooled and adjusted to
2  106 cells/mL in TCMmediumwith a hemocytometer using
the trypan blue dye exclusion method.
2.3. Effect of Q treatment on macrophages cell viability
To evaluate the possible cytotoxic effect of Q, the macrophage
cell viability was determined using a 3-(4,5-dimethylthiazol-2-
diphenyl)-2,5-tetrazolium bromide (MTT) assay. Briefly, peri-
toneal macrophages (2  106 cells/mL in TCM, 50 mL/well) in
the absence or presence of Q (88 mM in TCM, 50 mL/well) were
cocultured in 96-well plates at 37C in a humidified incubator
with 5%CO2 and 95% air for 24 hours. Aliquots of 10 mL of 5mg/
mL MTT (Sigma-Aldrich Co., St. Louis, MO, USA) in PBS were
added to each well in the 96-well plate. The plates were
incubated for another 4 hours. The culture medium was then
discarded. The plates were carefully washed with PBS buffer
twice. Aliquots of 100 mL of dimethyl sulfoxide were added to
each well and oscillated for 30 minutes to extract the formed
insoluble formazan. The absorbance was measured at 550 nm
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dorf, Austria). The cell viability of macrophages was calcu-
lated using the absorbance (A) at 550 nm:
Cell viability (% of control)¼ [(AsampleeAsample blank)/(Acontrole
Ablank)]  100. [1]
The remaining cell viability showed that Q treatment at a
final concentration of 44mM did not have any cytotoxic effect
on peritoneal macrophages. Thus, 44mM Q (¼ 15 mg/mL) was
adopted for use in the following cellular uptake and meta-
bolism experiments.
2.4. Determination of Q uptake and metabolism in
macrophages
To measure Q uptake and metabolism in mouse peritoneal
macrophages, Q (88mM, 100 mL/well), in the absence or pres-
ence of mouse peritoneal macrophages (2  106 cells/mL,
100 mL/well), were cocultured in 96-well plates. The plates
were incubated at 37C in a humidified incubator with 5% CO2
and 95% air for different time periods. After incubation for a
given time, the incubated fluid was centrifuged at 4C, 400  g
for 10minutes. Aliquots of 200 mL of fluid inmediumalone and
cell culture supernatants (namely, extracellular fluids) were
collected and stored in the dark at 80C for measuring indi-
vidual flavonoid contents. The cell pellets were carefully
washedwith PBS buffer twice, lysed, and shaken in the dark at
4C for 10 minutes with 200 mL of lysis buffer (pH 7.4) con-
taining 10 mL of 10mM tris(hydroxymethyl)aminomethane
(Tris, pH 7.4), 15 mL of 150mM NaCl, 10 mL of 5mM EDTA,
10 mL of 1mM sodium orthovanadate, 5 mL of 100 mg/mL
phenylmethylsulfonyl fluoride, 6 mg of 4 trypsin inhibitor
unit/mg aprotinin, 1 mL of 0.1% sodium dodecyl sulfate, and
1 mL of Triton X-100 in 100 mL solution [8]. The mixture was
allowed to stand at 4C for another 30 minutes. The resulting
mixtures were collected into an Eppendorf tube and centri-
fuged at 4C, 16,000  g for 20 minutes. The supernatants,
namely, intracellular fluids, were collected and another 8 mL
PBS was added. The fluids were stored in the dark at 80C
prior to determining individual flavonoid contents.
To extract total flavonoids from the samples, the sample
was added with an equal aliquot volume of 2M hydrochloric
acid (Wako) to precipitate the protein and increase flavonoid
recovery. The mixture was shaken and incubated in the dark
at room temperature for 30 minutes. After incubation was
completed, an aliquot of 15 mL ethyl acetate was added and
the mixture was shaken for another 3 minutes. The resultant
mixture was centrifuged at 400  g for 10 minutes at room
temperature. The top supernatant (about 15 mL) was
collected, and the bottom solution was added another 15 mL
ethyl acetate. The mixture was shaken for another 3 minutes
and centrifuged at 400  g for 10 minutes at room tempera-
ture. The top supernatant (about 15 mL) was collected and
pooled. The obtained ethyl acetate solution was mixed, and
the solvent was removed using a rotary vacuum evaporator
(EYELA; Tokyo Rikakikai Co., Ltd, Bohemia, NY, USA). The
residues were resuspended in 5 mL deionized water and
200 mL ethyl acetate. The extracts were lyophilized and
resuspended in 0.5 mL of methanol (HPLC-grade; Tedia Co.Inc., Fairfield, OH, USA) and filtered through a 0.2 mm filter
(Minisar SRP4, PTFE membrane; Sartorius, Goettingen, Ger-
many). The filtrate sample was stored in the dark at 80C
until use.
2.5. HPLC analysis of individual flavonoids
The sample solution was ultrasonically degassed prior to
HPLC analysis. Mobile phase A [double-distilled water:-
tetrahydrofuran (ECHO, Miaoli, Taiwan):trifluoroacetic acid
(Sigma-Aldrich Co., St. Louis, MO, USA) ¼ 98:2:0.1, v/v/v] and
mobile phase B (acetonitrile, HPLC grade; ECHO) were filtered
through a 0.45 mm filter (Durapore, Millipore, MA, USA) under
vacuum and ultrasonically degassed prior to use. The mobile
phase flow rate was 1 mL/min. Aliquots of 20 mL sample so-
lution were subjected to HPLC analysis. A pump (L-2131;
Hitachi, Tokyo, Japan), a UVevisible detector (L-2400; Hitachi),
and a chromatographic separation column (250  4.6 mm2,
5 mm; Mightsil RP-18 GP250; Kanto Chemical Co, Inc., Tokyo,
Japan) were used. The pump was controlled under the D-2000
Elite program (Hitachi): a gradient elution starting at 83%
mobile Phase A and 17% mobile Phase B for 7 minutes, fol-
lowed by 75% mobile phase A and 25% mobile Phase B for 8
minutes, 65% mobile Phase A and 35% mobile Phase B for 5
minutes, 50% mobile Phase A and 50% mobile Phase B for 7
minutes, 0% mobile Phase A and 100% mobile Phase B for 8
minutes, and ending at 83% mobile Phase A and 17% mobile
Phase B for 5 minutes. The detection was at 370 nm [5]. Seven
compounds, including rutin, ellagic acid, p-coumaric acid,
morin, Q, kaempferol, and isorhamnetin, were selected as
standards. The retention times (RTs) for rutin, ellagic acid, p-
coumaric acid, morin, Q, kaempferol, and isorhamnetin were
found at 10.4 minutes, 10.8 minutes, 11.4 minutes, 17.8 mi-
nutes, 19.7 minutes, 23 minutes, and 23.3 minutes, respec-
tively [5]. Individual compound quantification levels were
based on the peak integral area ratio between the standard
and sample. To compare changes in Q levels in extracellular
fluids, a relative uptake percentage was calculated using the
following equation:
Relative percentage of Q content (%)¼ (residual content of Q at
given incubation time/added original content of Q)  100. [2]
In intracellular fluids, a relative percentage of Q content
was calculated using the following equation:
Relative percentage of Q content (%)¼ [residual content of Q at
given incubation time/(added original content of Q e residual
content of Q in extracellular fluid at the given incubation
time)]  100. [3]
The relative percentage of Q content in intracellular fluids
was defined as the percentage of Q uptake by the cells.
2.6. Statistical analysis
Data were analyzed using theWindows SAS program (Version
8.0, SAS Institute Inc., Cary, NC, USA). Values were expressed
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terminations) using analysis of variance, if justified by the
statistical probability (p < 0.05), followed by Duncan's new
multiple range test. Differences were considered statistically
significant if p < 0.05.3. Results and discussion
We hypothesized that macrophages might take up Q and
further metabolize it into different metabolites. To confirm
this assumption, Q was incubated in the absence or presence
of mouse peritoneal macrophages for different time periods.
3.1. Effect of Q treatment on macrophage cell viability
In our previous study, we found that Q treatments at final
concentrations < 50mM did not produce cytotoxic effects on
the macrophages [6]. To avoid unpredictable cytotoxicities at
higher doses, an aliquot of 44mM Q was selected to reconfirm
the macrophage cell viability, indicating that 44mM Q did not
have any cytotoxic effect on macrophages (Fig. 1). Based on
the results, 44mM Q (¼ 15 mg/mL) was selected for use in the
following cellular uptake and metabolism experiments. In
addition, a bioavailability study on Q in rats fed 0.125%, 0.25%,
and 0.50% Q diet for 10 days reflected 45± 6mM, 79± 7mM, and
118± 8mM of plasma Q concentrations, respectively [9].
Evidently, 44mM Q selected for use in the present study is safe
and possible to reach in vivo.Treatment
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Fig. 1 e Effect of quercetin treatment on the macrophage
cell viability. Values are expressed as means ± SEM (n ¼ 6
biological determinations), analyzed using one-way
ANOVA, followed by Duncan's multiple range tests. There
are no significant differences between quercetin treatment
and the control. The original cell density was 1 £ 106 cells/
mL. ANOVA ¼ analysis of variance; SEM ¼ standard error
of the mean.3.2. Changes in levels of Q and its metabolites in
medium alone or macrophage extracellular fluid treated
with Q through different incubation times
Changes in Q and its metabolites in medium alone (Fig. 2) and
extracellular fluids of macrophages cultured with Q for
different time periods (Fig. 3) are shown as HPLC chromato-
grams. Levels of Q and its metabolites in medium alone and
extracellular fluids of macrophages incubated for different
time periods were analyzed according to their HPLC chro-
matograms. The results showed that Q levels in medium
alone decreased markedly as the incubation time was
extended, indicating that Q was unstable and readily oxidized
itself (Fig. 4A). Accordingly, isorhamnetin (30-O-methyl quer-
cetin; Fig. 4A), kaempferol, unknown Q metabolites (UQMs,
RT: 20.7 minutes and 25 minutes), and other trace metabolites
(RT: 7.6 minutes; Fig. 4B) were found. Importantly, the rela-
tionship between Q and isorhamnetin showed a negative
correlation as the incubation time was extended, suggesting
that isorhamnetin might be a major spontaneous metabolite
of Q (Fig. 4A). Isorhamnetin levels increased gradually and
achieved its maximal concentration at 12 hours of incubation.
However, isorhamnetin was still unstable in medium alone.
Its level decreased after 18 hours of incubation and might be
remetabolized into another secondary metabolite (Fig. 4A). In
the meantime, kaempferol and other unknown metabolites
(RT ¼ 7.6 minutes, 20.7 minutes, and 25 minutes) increased
markedly as Q levels decreased, suggesting that kaempferol
and other unknown metabolites (RT ¼ 7.6 minutes, 20.7 mi-
nutes, and 25 minutes) are also spontaneous metabolites of Q
(Fig. 4B). Unfortunately, some unknown metabolites (RT ¼ 7.6
minutes, 20.7minutes, and 25minutes) could not be identified
in this study. We hypothesized that these unknown metabo-
lites (RT ¼ 7.6 minutes, 20.7 minutes, and 25 minutes) were
primary or secondary metabolites of Qdisorhamnetin or
kaempferol.
Fig. 4C and D show changes in levels of Q and its metabo-
lites in the extracellular fluid of peritoneal macrophages
cultured with Q for different time periods. Similar to those in
medium alone, Q and isorhamnetin showed a negative cor-
relation as the incubation time was extended, suggesting that
isorhamnetin is a major metabolite of Q in either the absence
or the presence of peritoneal macrophages (Fig. 4C and D).
Compared with the results from medium alone (Fig. 4A), iso-
rhamnetin levels in the presence of macrophages increased
quickly at 6 hours of incubation and achieved maximal con-
centration twice compared to that in medium alone, sug-
gesting that macrophages enhance isorhamnetin production
(Fig. 4C). Furthermore, isorhamnetin levels in both medium
alone and macrophage extracellular fluids decreased to a
similar low concentration at 24 hours of incubation, suggest-
ing that nascent isorhamnetin in the extracellular fluid might
subsequently enter the cells. In addition to isorhamnetin,
kaempferol and other unknown metabolites (RT ¼ 7.6 mi-
nutes, 20.7 minutes, and 25 minutes) increased markedly as
the Q levels decreased, suggesting that kaempferol and other
UQMs [RT ¼ 20.7 minutes (UQM1), 25 minutes (UQM2), and 7.6
minutes (UQM3)] are also Q metabolites outside of macro-
phages (Fig. 4D). Compared with the results from medium
Fig. 2 e HPLC chromatograms showing quercetin metabolism in medium alone for different time periods. HPLC ¼ high-
performance liquid chromatography; I ¼ isorhamnetin (3′-O-methyl quercetin); K ¼ kaempferol; Q ¼ quercetin;
UQM ¼ unknown quercetin metabolite.
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decreased slowly as the incubation time was extended, sug-
gesting that macrophages might enhance kaempferol pro-
duction and a little amount of nascent kaempferolmight enter
the cells (Fig. 4D). Other changes in the levels of UQMs had theFig. 3 e HPLC chromatograms showing extracellular fluid from p
time periods. HPLC¼ high-performance liquid chromatography
Q ¼ quercetin; UQM ¼ unknown quercetin metabolite.same trend. Interestingly, an UQM (UQM4, RT ¼ 9.9 minutes)
just appeared in the macrophages, but not in medium-alone
cultures. The nascent metabolites and remaining Q might
subsequently enter the cells. Unfortunately, the unknown
metabolites could not be identified in this study. However, oureritoneal macrophages cultured with quercetin for different
; I ¼ isorhamnetin (3′-O-methyl quercetin); K¼ kaempferol;
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Fig. 4 e Changes in levels of quercetin and its metabolites in medium in the (A and B) absence or (C and D) presence of
macrophages through different incubation times and (E) a proposed quercetin metabolic pathway. Values are presented as
means ± SEM (n ¼ 6 biological determinations) according to HPLC chromatograms. The original cell density was 1 £ 106
cells/mL. RT values were as follows: UQM1, 20.7 minutes; UQM2, 25 minutes; UQM3, 7.6 minutes; and UQM4, 9.9 minutes.
HPLC ¼ high-performance liquid chromatography; RT ¼ retention time; SEM ¼ standard error of the mean;
UQM ¼ unknown quercetin metabolite.
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into isorhamnetin or kaempferol in the absence or presence of
macrophages (Fig. 4E).
3.3. Changes in levels of Q and its metabolites in
intracellular fluids of peritoneal macrophages through
different incubation times
Changes in the levels of Q and its metabolites in intracellular
fluids of macrophages through different incubation times
were measured using HPLC (Fig. 5). The levels of Q and its
metabolites in intracellular fluids of macrophages were
analyzed according to HPLC chromatograms (Fig. 6). The re-
sults showed that Q increased quickly and markedly in the
intracellular fluid at 0 hour of incubation, indicating that most
of Q was readily absorbed by macrophages. Furthermore, a
trace amount of isorhamnetin (RT ¼ 23.3 minutes) and an
unknown metabolite (RT ¼ 25 minutes, UQM2) that had been
metabolized from Q outside the cells were found in the
intracellular fluid at 0 hour of incubation, suggesting that
isorhamnetin (RT ¼ 23.3 minutes) and the unknown metabo-
lite (RT ¼ 25 minutes, UQM2) were also readily absorbed by
macrophages. Interestingly, a novel unknown flavonoid
compound (RT ¼ 26.3 minutes) was also found in the macro-
phage intracellular fluid. The novel compound (RT ¼ 26.3
minutes) was considered an endogenous Q metabolite (EQM)
in the cells. As the incubation time was extended to 6 hours, Qlevel decreased, whereas that of isorhamnetin increased, but
levels of other metabolites (RT ¼ 25 minutes and RT ¼ 26.3
minutes) also decreased, indicating that isorhamnetin is a
majormetabolite of Q inmacrophages. As the incubation time
was extended to 12e24 hours, the levels of Q and all its me-
tabolites decreased markedly, indicating that Q might be
totally metabolized within 12e24 hours in macrophages
(Fig. 6). Taken together, our results showed that Q, iso-
rhamnetin, and UQM2 (RT¼ 25minutes) might be absorbed by
the macrophages (Fig. 6). The percentage of maximal uptake
of Q was found to be 2.28% immediately after incubation;
however, the uptake of Q persisted for about 24 hours (Fig. 7).
It was found that quercetin glucosides can be transported by
sodium-dependent glucose transporter SGLT1 across the
apical membrane of enterocytes [10]. We presumed that Q, in
its aglyconic form, could not enter immune cells through
sodium-dependent glucose transporter, resulting in its low
availability to immune cells or tissues [11]. Even though the
percentage of maximal Q uptake by macrophages was just
2.28%, Q may have significant beneficial effects on immune
cells. As Q entered the macrophages, it was further metabo-
lized into isorhamnetin and an unknown EQM. Q itself has
been found to inhibit endothelial nitric oxide synthase,
microtubule polymerization, and mitotic progression in
bovine aortic endothelial cells, suggesting that Q may have a
potential role as a chemopreventive agent via suppressing
endothelial cell proliferation and angiogenesis [12].
Fig. 5 e HPLC chromatograms showing intracellular fluid of peritoneal macrophages cultured with quercetin for different
time periods. EQM ¼ endogenous quercetin metabolite; HPLC ¼ high-performance liquid chromatography;
I¼ isorhamnetin (3′-O-methyl quercetin); K¼ kaempferol; Q¼ quercetin; TCM¼ tissue culture medium; UQMs¼ unknown
quercetin metabolites.
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cyclooxygenase-2 transcription in human lymphocytes,
exhibiting anti-inflammatory potential [13].
According to our data, we assumed that a catechol-O-
methyltransferase was synthesized by macrophages to
metabolize Q into isorhamnetin in both extra- and intra-
cellular fluids [14]. It is reported that the extensive
methylation of Q was found to limit its bioavailability in
HepG2 cells [15]. Surco-Laos et al [16] also indicated a
greater uptake of Q than its methylated derivatives by the
nematode. Our results were identical to those of previous
studies [15,16]. We also found that only a trace amount of
isorhamnetin (30-O-methyl quercetin) in extracellular fluid
was absorbed by macrophages (Fig. 6A). In addition, flavo-
noids containing a catechol or dihydroxylated B-ring (e.g.,
Q) are easily oxidized. The oxidation may be carried out
under physiological conditions or in medium alone in the
presence of transition metals such as iron or copper. In the
present study, we evidenced that Q might easily be
metabolized into kaempferol due to spontaneous oxidation
in the absence or presence of immune cells. Furthermore,
certain enzymes such as tyrosinase or peroxidases may
catalyze quinine formation. Q autoxidation in cells may
also result in the production of reactive quinone and
quinone methide species that are capable of reacting with
cellular biomolecules and/or cellular thiols such asglutathione and protein cysteine residues. Enzymatic
oxidation of flavonoids may be beneficial to clear flavonoids
from the cells via a reaction between quinone and gluta-
thione, exporting the conjugate [17]. Uptake experiments
using dermal fibroblasts indicated that exposure to Q
resulted in the generation of two novel cellular metabolites,
a 20-glutathionyl Q conjugate and another product, puta-
tively a quinone/quinone methide, suggesting that its for-
mation is related to oxidative metabolism [18]. Based on our
results, we hypothesized that tyrosinase, peroxidases, or
quinone reductase might be produced by macrophages to
metabolize Q outside or inside of cells into O-semiquinone
(possibly UQM2), O-quinone (possibly UQM1) or quercetin
quinoid (quinine methide) [17e20]. Most importantly, the
present study exhibited that Q itself and some of its me-
tabolites, including isorhamnetin and O-semiquinone
(possibly UQM2), could enter macrophages, performing
immunoregulatory functions in macrophages, subsequently
producing some unidentified EQMs and isorhamnetin.
Recently, Q was found to suppress lead-induced inflam-
matory response in rat kidneys through the reactive oxygen
species-mediated mitogen-activated protein kinases and
nuclear factor-kB pathway [21]. Most recently, Q has been
used in cancer prevention and therapy [22]. Unraveling Q
uptake and metabolism using macrophages might further
clarify Q immune effects. We have achieved some
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Fig. 6 e Changes in levels of quercetin and its metabolites
in intracellular fluids of peritoneal macrophages cultured
with quercetin through different incubation time. Values
are presented as means ± SEM (n ¼ 6 biological
determinations) according to HPLC chromatograms. The
original cell density was 1 £ 106 cells/mL.
EQM ¼ endogenous quercetin metabolite; HPLC ¼ high-
performance liquid chromatography; RT ¼ retention time;
SEM ¼ standard error of the mean; UQM ¼ unknown
quercetin metabolites.
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Fig. 7 e Changes in levels of quercetin in extra- and
intracellular fluids of peritoneal macrophages. Values are
presented as means ± SEM (n ¼ 6 biological
determinations) according to HPLC chromatograms. The
original cell density was 1 £ 106 cells/mL. Points in the
same plot without sharing a common letter are
significantly different (p < 0.05) from each other assayed by
one-way ANOVA, followed by Duncan's multiple range
test. The relative percentage of quercetin content (%) ¼
(residual content of quercetin at given incubation time/
added original content of quercetin) £ 100. In intracellular
fluids, a relative percentage of quercetin content was
calculated using the following equation: relative
percentage of quercetin content (%) ¼ [residual content of
quercetin at given incubation time/(added original content
of quercetin e residual content of quercetin in extracellular
fluid at the given incubation time)] £ 100.
ANOVA ¼ analysis of variance; HPLC ¼ high-performance
liquid chromatography; SEM¼ standard error of the mean.
j o u r n a l o f f o o d and d ru g an a l y s i s 2 3 ( 2 0 1 5 ) 6 9 2e7 0 0 699important results in the present study, although more data
should be accumulated to further clarify Q cellular signaling
in macrophages.
This study has some limitations. First, Q metabolites could
be formed inside the macrophages and diffused into the
extracellular medium. Our hypothesis that extracellular en-
zymes were involved might not be absolutely correct. Exper-
iments with macrophage-conditioned medium should be
performed to substantiate this hypothesis. Uptake and
metabolic inhibitors should be performed in the macrophage
uptake study to confirmQ biotransformation in immune cells.4. Conclusion
Our results indicated that Q was unstable and easily oxidized
in either the absence or the presence of macrophages. The
remaining Q and its metabolites, including isorhamnetin andan UQM [possibly Qe (O-semiquinone)] might be absorbed by
macrophages. The percentage of maximal Q uptake by mac-
rophageswas found to be 2.28% immediately after incubation;
however, the uptake of Qmight persist for about 24 hours. The
uptake of Q by macrophages was greater than that of its
methylated derivative isorhamnetin. As Q or its metabolites
entered macrophages, those compounds were metabolized
primarily into isorhamnetin, kaempferol, or EQMs.Conflicts of interest
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